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might help the attending anaesthesiologist to formulate a strategy to allay
the anxiety in these patients. This is the pioneer study highlighting a very
high desire for information not only for surgery but also for anaesthesia
among neurosurgical patients of a developing country. Our study was
limited by recruitment of all the patients from 1 centre so culture and
clinic specific factors can alter the findings.
[SNACC-120] Evaluation of the PEGASUS Clinical Pathway
Implementation on Severe Pediatric Traumatic Brain Injury
Patients
Yang J*, King M†, Blayney C†, Johnston B‡, Kim J‡, Vavilala M*,
Chesnut R‡. *University of Washington. †Seattle Children’s Hospital.
‡Harborview Medical Center, Seattle, WA.
Background: Traumatic brain injury (TBI) is a leading cause of disability
and death and a significant public health problem. Adherence to evidence
based guidelines is associated with improved discharge survival in severe
pediatric TBI. Three key performance indicators (KPIs), namely
avoidance of unwanted hyperventilation in the absence of herniation,
maintenance of all cerebral perfusion pressure (CPP) > 40mmHg, and
start of nutrition within 72 hours, are protective. The Pediatric Guideline
Adherence and Outcomes (PEGASUS) program is a multilevel, im-
plementation science guided, comprehensive quality improvement effort
developed in 2011 and implemented in 2014 at Harborview Medical
Center (HMC) that includes clinical protocol (KPIs), value added pro-
cesses, and provider perspectives. We hypothesized that implementation
of PEGASUS program is associated with improved adherence to KPIs
and favorable discharge outcomes.
Methods: This is a quasiexperimental, pre-post interventional study. After
IRB approval, data were extracted from the Harborview Trauma Registry
and electronic medical record system. Program phases were Baseline
(January 2007 to December 2011), Development (April 2011 to March
2014), and Implementation phase (from April 2014 to December, 2016).
Inclusion criteria were patients age older than 18 years, TBI, admission
Glasgow Coma Scale (GCS) <9, and abnormal head CT. Patients admitted
with less than severe TBI but who deteriorated were included. KPI ad-
herence and favorable discharge disposition (discharge home or re-
habilitation) were examined across PEGASUS phases. χ2 and Student t test
were used for univariate tests. P-values are compared with baseline phase.
Results: A total of 56 patients from baseline phase (5 y), 103 patients from
development phase (3 y), and 89 patients from implementation phase
(2.75 y) were identified. Avoidance of unwanted hyperventilation in-
creased from 12.5% to 61% and 69.2% (both P< 0.0001), all CPP
maintained > 40mmHg remained the same at 69.6%, 62% (P= 0.23),
and 60% (P= 0.14), Nutrition initiation within 72 hours increased non-
significantly from baseline at 91.1%, to 84% (P= 0.13), and finally to
94.2% (P= 0.42). Favorable discharge disposition increased from 55.4%
to 70.3% (P= 0.03) and 71.9% (0.01).
Discussion: Implementation of the PEGASUS program increased ad-
herence to the ventilation KPI and improved discharge outcome. The
change in nutrition was less sensitive to PEGASUS program im-
plementation, possibly due to relatively high baseline adherence rate.
CPP maintenance rates did not change but efforts made to increase CPP
were noted by nursing staff.
[SNACC-121] Towards Personalized Anesthesia: Predictive Fac-
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Aberta. †Universidade Do Porto. ‡Centro Hospitalar Do Porto, Porto,
Portugal.
The importance of personalized medicine is becoming increasingly rec-
ognized. We previously reported a wide variability in individual patient
propofol requirements for loss of consciousness (LOC).1 The aim of this
study was to identify the physiologic variables that may contribute to the
observed interindividual variability.
Data of 217 adult patients submitted to neurosurgical procedures were
retrospectively analyzed. Only patients submitted to TIVA with propofol
and remifentanil were considered. In all cases 1% propofol was infused at
a slow rate (around 200mL/h) with a TCI pump, to allow the precise
identification of the amount required for LOC. LOC was identified as
lack of eye opening to name calling and a tap on the forehead. Variables
considered for analysis were: age, weight, height, lean body mass, sex,
ASA status, type of surgery, baseline arterial pressure, baseline heart rate
and baseline BIS value. The amount of propofol (mg) required for LOC,
the propofol predicted effect-site concentration (EC ug/mL) at LOC
(Schnider’s PK model), and the induction sequence (propofol or opioid
first) were also noted. Multivariate Regression Analysis was used to de-
termine if any of the patient data and baseline recordings were predictors
of the propofol amount (mg or mg/kg) required for LOC, or of the
predicted propofol EC at LOC.
The propofol EC ug/mL at LOC: IQ range (3.1 to 5.3) (71%). The total
amount of propofol in mg at LOC: IQ range (71.8 to 116.3) (62%).
Propofol for LOC in mg/kg: IQ range (1.1 to 1.7) (55%).
The identified independent predictive factors for the propofol EC at LOC
were: sex (P< 0.001) and baseline SAP (P< 0.001), with R2= 0.25
(P< 0.001). For the propofol total amount in milligrams required for
LOC the identified independent predictive factors were: age (P< 0.001),
sex (P= 0.018), weight (P= 0.009), and baseline SAP (P< 0.001), with
R2= 0.31 (P< 0.001). For the propofol total amount in mg/kg the in-
dependent predictive factors were: age (P< 0.001), sex (P= 0.045), weight
(P< 0.001) and baseline SAP (P< 0.001), with R2= 0.3 (P< 0.001). For
all, the female sex and age decreased the propofol requirements, while
higher SAP baseline values increased the propofol requirements.
We show a wide variability in individual patient propofol requirements to
induce LOC, which is critical. This variability was observed even when
EC were used, although PK models already incorporate sex, age, weight,
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and height. Interestingly, the baseline SAP and sex, proved to be in-
dependent predictive factors and explained at least 25% of the variability.
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[SNACC-122] A Survey Assessing Attitudes Regarding Neuro-
anesthesia Fellowship Amongst Attending Anesthesiologists, Fel-
lows and Residents
Rajan S*, Theard M†, Easdown J‡, Pasternak J§. *Cleveland Clinic,
Cleveland, OH. †Oregon Anesthesiology Group, Portland, OR. ‡4648 the
Vanderbilt Clinic, Nashville, TN. §Mayo Clinic, Rochester, MN.
Background: Despite advances in the exciting field of neuro-
anesthesiology, the number of residents applying for a neuroanesthesia
fellowship is still low compared with other anesthesiology fellowship
programs. We conducted a survey on behalf of the Society for Neuro-
science in Anesthesiology and Critical Care (SNACC) Neuroanesthesia
Education Special Interest Group (SIG) to assess attitudes regarding
neuroanesthesia fellowship training.
Methods: The survey was administered to all e-mail addresses contained
within SNACC’s database and was also administered to members of
the Society for Education in Anesthesiology (SEA) and the Society of
Academic Anesthesiology Associations (SAAA). Additionally, members
of the SNACC board of directors were asked to distribute the survey to
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